Health Care Law Today Podcast

We are excited to announce a special series, TLDR. TLDR is focused on the digital health industry and the lawyers operating inside the companies innovating in the space, their work, the industry, and their experiences. In this episode of TLDR, my colleague Evan Hellman is joined by Michelle McGovern, General Counsel of Verana Health, to discuss issues associated with the current legal environment for telemedicine companies and the everyday hustle and bustle of a being a General Counsel.

In this episode, Partner and Co-Chair of the Firm’s Health Care Practice Group, and Partner Monica Chmielweski are joined by Jodi Akin, Founder and CEO of Hawthorne Effect. Hawthorne Effect has embraced the decentralized clinical trial model and is dedicated to enriching the quality, experience, diversity, and access to clinical trials for patients, providers, and sponsors. With Jodi, we explore the newly released FDA Guidance, Decentralized Clinical Trials for Drugs, Biological Products, and Devices, and how Hawthorne Effect was positioned for this guidance and what steps it will take to adapt its practices. We also explore the unique opportunities afforded by conducting decentralized clinical trials

In this episode, Foley partner Anil Shankar sits with Jackie Bender, Chief of Finance Strategy for the Los Angeles County Department of Health Services, to discuss California and Los Angeles County’s recently approved Medicaid waiver called CalAIM (California Advancing and Innovating Medi-Cal), the multiyear care delivery and payment reform initiative led by the California Department of Health Care Services (DHCS).

In this episode, Foley Partners Adria Warren and Alexis Bortniker sit with Michael Kolodziej of ADVI Health about the upcoming Cancer Center Business Summit and the current convergence and consolidation in the oncology industry and what that means for the future of cancer care.ACCC 48th ANNUAL MEETING & CANCER CENTER BUSINESS SUMMITWe are thrilled to announce that the ACCC 48th Annual Meeting & Cancer Business Summit (AMCCBS) will now be offered as a hybrid event—with limited in-person attendance and an all-new livestreaming options—March 2-4 at the Washington Hilton in Washington, DC. Explore cutting-edge solutions to persistent challenges and navigate our shifting cancer care landscape during our newly streamlined programming, creating a more intimate setting that delivers all-new, targeted education and networking experiences. We are committed to offering opportunities to collaborate, grow, and transform—whether in-person or virtually. Over a three-day period, AMCCBS will offer more than 20 interactive sessions that will be equally as engaging whether onsite in DC or streaming live directly to you. All sessions will be livestreamed in real-time, allowing attendees the ability to have their questions answered by speakers in real-time. To register for the conference, please visit the conference website.

In this episode, Foley Of Counsel Maureen Kwiecinski sits with Alexandra Glazier of New England Donor Services (NEDS) about how Organ Procurement Organizations (OPOs) are regulated and some of the recent changes in performance and outcome standards, similar to other health care organizations. 

In this episode, Foley Senior Counsel Adam Hepworth talks with Trent Stechschulte of Equitas Health to talk about current hot issues related to Federally Qualified Health Centers (FQHCs).

In this episode, Foley Partner Holden Brooks sits down with Drs. Monica Noether and Sean May, who are Vice Presidents at Charles River Associates (CRA), to explore the ways that economists add value to provider clients who are considering transactions. They will explain what it is that economists can bring to the table, their flexibility in structuring these kinds of engagements, and get a sense for what they see emerging as trends in the provider transaction space.